Baden LR, Shah NS, Liu STH, Cohen J, et al. Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition
(long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind,
placebo-controlled, phase 2 trial. Lancet Infect Dis 2026 Aug 31:S1473-3099(26)00406.
PMID: 42673984
|